Crossmark

The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells

Crossref DOI link: https://doi.org/10.1007/s00280-014-2465-1

Published Online: 2014-04-18

Published Print: 2014-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Azijli, Kaamar

van Roosmalen, Ingrid A. M.

Smit, Jorn

Pillai, Saravanan

Fukushima, Masakazu

de Jong, Steven

Peters, Godefridus J.

Bijnsdorp, Irene V.

Kruyt, Frank A. E.
License Information

Text and Data Mining valid from 2014-04-18